In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
DENTSPLY Sirona Inc (NASDAQ: XRAY) closed the day trading at $15.99 down -3.38% from the previous closing price of $16.55. In other words, the price has decreased by -$3.38 from its previous closing price. On the day, 4.73 million shares were traded.
Ratios:
For a better understanding of XRAY, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.70 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.32. For the most recent quarter (mrq), Quick Ratio is recorded 0.74 and its Current Ratio is at 1.10. In the meantime, Its Debt-to-Equity ratio is 1.17 whereas as Long-Term Debt/Eq ratio is at 0.86.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on February 14, 2025, initiated with a Equal Weight rating and assigned the stock a target price of $20.
On January 23, 2025, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $30 to $20.
Evercore ISI Downgraded its Outperform to In-line on January 07, 2025, while the target price for the stock was maintained at $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 03 ’25 when LUCIER GREGORY T bought 15,142 shares for $16.51 per share. The transaction valued at 249,994 led to the insider holds 81,971 shares of the business.
Coleman Glenn bought 15,759 shares of XRAY for $311,240 on Jan 27 ’25. On Nov 18 ’24, another insider, LUCIER GREGORY T, who serves as the Director of the company, bought 5,000 shares for $18.37 each. As a result, the insider paid 91,850 and bolstered with 71,730 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.84 while its Price-to-Book (P/B) ratio in mrq is 1.64.
Stock Price History:
Over the past 52 weeks, XRAY has reached a high of $34.91, while it has fallen to a 52-week low of $16.21. The 50-Day Moving Average of the stock is -14.84%, while the 200-Day Moving Average is calculated to be -30.50%.
Shares Statistics:
A total of 198.80M shares are outstanding, with a floating share count of 197.76M. Insiders hold about 0.62% of the company’s shares, while institutions hold 102.86% stake in the company.
